Literature DB >> 15208664

Involvement of c-Src kinase in the regulation of TGF-beta1-induced apoptosis.

Seok Soon Park1, Young-Woo Eom, Eun Hee Kim, Ji Hyun Lee, Do Sik Min, Sungsub Kim, Seong-Jin Kim, Kyeong Sook Choi.   

Abstract

Transforming growth factor-beta1 (TGF-beta1) is a potent inducer of apoptosis in normal hepatocytes, and acquiring resistance to TGF-beta1 may be a critical step in the development of hepatocellular carcinoma (HCC). In this study, we investigated the possible involvement of c-Src in the regulation of TGF-beta1-induced apoptosis. TGF-beta1 induced transient activation of c-Src and its subsequent caspase-mediated degradation concomitant with cell death in FaO hepatoma cells, which are sensitive to TGF-beta1. In response to TGF-beta1, activated c-Src was translocated into the cytoplasmic membrane, then relocated to the nuclei of apoptotic cells during its cleavage. In TGF-beta1-induced apoptotic cells, c-Src maintained its tight association with p85 FAK fragment cleaved by caspases, possibly contributing to focal adhesion disassembly. TGF-beta1-induced apoptosis was enhanced by either inhibition of c-Src activity using PP1 or PP2, or by overexpression of dominant-negative c-Src. In contrast, overexpression of constitutively active c-Src inhibited apoptosis suppressing TGF-beta1-induced activation of p38, JNK and caspases. In many HCC cell lines resistant to TGF-beta1, enhanced c-Src activity was detected. We hypothesize that activated c-Src in HCC may contribute to resistance against the apoptotic and/ or antiproliferative properties of TGF-beta1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15208664     DOI: 10.1038/sj.onc.1207856

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  30 in total

1.  Aberrant signaling pathways in pancreatic cancer: a two compartment view.

Authors:  Angela L McCleary-Wheeler; Robert McWilliams; Martin E Fernandez-Zapico
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  Human remyelination promoting antibody inhibits apoptotic signaling and differentiation through Lyn kinase in primary rat oligodendrocytes.

Authors:  J Watzlawik; E Holicky; D D Edberg; D L Marks; A E Warrington; B R Wright; R E Pagano; M Rodriguez
Journal:  Glia       Date:  2010-11-15       Impact factor: 7.452

3.  Inactivation of TGFbeta signaling in neural crest stem cells leads to multiple defects reminiscent of DiGeorge syndrome.

Authors:  Heiko Wurdak; Lars M Ittner; Karl S Lang; Per Leveen; Ueli Suter; Jan A Fischer; Stefan Karlsson; Walter Born; Lukas Sommer
Journal:  Genes Dev       Date:  2005-03-01       Impact factor: 11.361

4.  Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma.

Authors:  Priya Koppikar; Seung-Ho Choi; Ann Marie Egloff; Quan Cai; Shinsuke Suzuki; Maria Freilino; Hiroshi Nozawa; Sufi M Thomas; William E Gooding; Jill M Siegfried; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

Review 5.  Apoptosis in liver carcinogenesis and chemotherapy.

Authors:  Joaquim Moreno-Càceres; Isabel Fabregat
Journal:  Hepat Oncol       Date:  2015-11-11

6.  Transforming growth factor-β decreases side population cells in hepatocellular carcinoma in vitro.

Authors:  Jong Bin Kim; Seulki Lee; Hye Ri Kim; Seo-Young Park; Minjong Lee; Jung-Hwan Yoon; Yoon Jun Kim
Journal:  Oncol Lett       Date:  2018-04-05       Impact factor: 2.967

Review 7.  Targeting the transforming growth factor-beta signaling pathway in human cancer.

Authors:  Nagathihalli S Nagaraj; Pran K Datta
Journal:  Expert Opin Investig Drugs       Date:  2010-01       Impact factor: 6.206

8.  Biology of SNU cell lines.

Authors:  Ja-Lok Ku; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

9.  Involvement of Src tyrosine kinases (SFKs) and of focal adhesion kinase (FAK) in the injurious mechanism in rat primary neuronal cultures exposed to chemical ischemia.

Authors:  Vered Shani; Yael Bromberg; Oded Sperling; Esther Zoref-Shani
Journal:  J Mol Neurosci       Date:  2008-06-27       Impact factor: 3.444

Review 10.  Mechanisms of the epithelial-mesenchymal transition by TGF-beta.

Authors:  Michael K Wendt; Tressa M Allington; William P Schiemann
Journal:  Future Oncol       Date:  2009-10       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.